Oct 2020 – SELENA+ received regulatory approval for commercialisation from ANVISA (Agência Nacional de Vigilância Sanitária) or the National Health Surveillance Agency. ANVISA is the regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices in Brazil.

Brazil is one of the 20 countries of the International Diabetes Federation (IDF) South America/Central America (SACA) region. According to IDF’s latest statistics, 463 million people have diabetes in the world and more than 32 million people in the SACA Region; by 2045 this will rise to 49 million. Brazil has a population of 210 million and a diabetic prevalence of about 12%.

View our product registration on ANVISA website here:


Please direct all queries related to this article to Marketing at


Comments are closed.